Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Dunbar, A. J., Bowman, R. L., Park, Y. C., O’Connor, K., Izzo, F., Myers, R. M., Karzai, A., Zaroogian, Z., Kim, W. J., Fernández-Maestre, I., Waarts, M. R., Nazir, A., Xiao, W., Codilupi, T., Brodsky, M., Farina, M., Cai, L., Cai, S. F., Wang, B., … Levine, R. L. (2024). Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms. Cancer Discovery, 14(5), 737–751. https://doi.org/10.1158/2159-8290.cd-22-0952
Authors:
Andrew J Dunbar
Robert L Bowman
Young C Park
Kavi O'Connor
Franco Izzo
Robert M Myers
Abdul Karzai
Zachary Zaroogian
Won Jun Kim
Inés Fernández-Maestre
Michael R Waarts
Abbas Nazir
Wenbin Xiao
Tamara Codilupi
Max Brodsky
Mirko Farina
Louise Cai
Sheng F Cai
Benjamin Wang
Wenbin An
Julie L Yang
Shoron Mowla
Shira E Eisman
Amritha Varshini Hanasoge Somasundara
Jacob L Glass
Tanmay Mishra
Remie Houston
Emily Guzzardi
Anthony R Martinez Benitez
Aaron D Viny
Richard P Koche
Sara C Meyer
Dan A Landau
Ross L Levine
Affiliated Authors:
Aaron D Viny
Columbia Affiliation:
Subjects:
Janus Kinase 2 (MeSH)
Myeloproliferative Disorders (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1158/2159-8290.cd-22-0952
PMID:
38230747
DOI:
10.1158/2159-8290.cd-22-0952
Journal:
Cancer Discovery
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: